Preclinical development of BCG.HIVA2auxo.int, harboring an integrative expression vector, for a HIV-TB Pediatric vaccine. Enhancement of stability and specific HIV-1 T-cell immunity. (2017)

First Author: Mahant A

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/21645515.2017.1316911

PubMed Identifier: 28426273

Publication URI: http://europepmc.org/abstract/MED/28426273

Type: Journal Article/Review

Volume: 13

Parent Publication: Human vaccines & immunotherapeutics

Issue: 8

ISSN: 2164-5515